Advanced Accelerator Applications SA, a specialist in nuclear medicine, has announced the appointment of Kapil Dhingra as an independent non-executive director. Dr Dhingra has more than 25 years of experience in oncology drug development including nine at the pharmaceutical division of Roche where he was most recently head of oncology clinical development. Prior to this he worked in the oncology clinical development group at Eli Lilly and Company.
Dr Dhingra is head of KAPital Consulting, a healthcare consulting firm that he founded in 2008. He holds a medical degree from the All India Institute of Medical Sciences.
AAA announced the appointment on 29 April 2014.
Copyright 2014 Evernow Publishing Ltd